ADENOSQUAMOUS CELL CARCINOMA

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting ADENOSQUAMOUS CELL CARCINOMA:

# Drug Count
0 AFATINIB 3
1 CARBOPLATIN 3
2 DOCETAXEL 3
3 DOCETAXEL ANHYDROUS 3
4 ERLOTINIB HYDROCHLORIDE 3
5 ETOPOSIDE 3
6 PEMETREXED 3
7 PEMETREXED DISODIUM 3
8 TOPOTECAN 3
9 DEXAMETHASONE 2
See all common drugs associated with ADENOSQUAMOUS CELL CARCINOMA

ADENOSQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN 3 0.0005
1 AFATINIB 3 0.0005
2 FRUQUINTINIB 1 0.0003
3 ERLOTINIB HYDROCHLORIDE 3 0.0002
4 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 1 0.0002
5 ALECTINIB HYDROCHLORIDE 1 0.0001
6 FELODIPINE 1 0.0001
7 PEMETREXED DISODIUM 3 0.0001
8 BISACODYL SUPPOSITORIES 1 0.0001
9 BISCODYL 1 0.0001
See all drugs enriched for association with ADENOSQUAMOUS CELL CARCINOMA